Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

Please provide your email address to receive an email when new articles are posted on . Targeted vitamin D supplementation did not reduce major adverse cardiovascular events in patients with a prior ...

For the past 20 years, many of the dramatic improvements in cancer outcomes can be attributed to personalized cancer treatments based upon DNA mutations in a tumor. Targeted therapies — often one pill ...

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses the latest advancements in HR+/HER2– breast cancer research, as well as the ...

Lung cancer in never-smokers exhibits distinct biological characteristics, often leading to late-stage diagnoses due to lack of screening. Targeted therapies, guided by molecular testing, offer ...

Targeted violence and terrorism continue to pose an urgent threat to public safety and national security. Ranging from school shootings to acts of mass violence, targeted violence and terrorism ...